These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9407216)

  • 21. Liability issues with the Papanicolaou smear: a defense lawyer's perspective.
    Varner CD
    Arch Pathol Lab Med; 1997 Mar; 121(3):315-20. PubMed ID: 9111126
    [No Abstract]   [Full Text] [Related]  

  • 22. Sensitivity of primary screening by rapid review: 'to act or not to act on the results, that is the question'.
    Slater DN
    Cytopathology; 1998 Apr; 9(2):77-83. PubMed ID: 9577733
    [No Abstract]   [Full Text] [Related]  

  • 23. Papanicolaou Society of Cytopathology guidelines for educational notes, disclaimers, and similar comments on reports of cervical cytology specimens.
    Papanicolau Society of Cytopathology Practice Guidelines Task Force
    Diagn Cytopathol; 2003 May; 28(5):282-5. PubMed ID: 12722126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How preventable is invasive cervical cancer? A community study of preventable factors.
    Martin PL
    Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):114-21. PubMed ID: 5164820
    [No Abstract]   [Full Text] [Related]  

  • 25. [Factors which affect cytodiagnosis in gynecology].
    Kobilková J; Lojda Z; Dusková J; Beková A
    Cesk Patol; 2001 Jan; 37(1):10-4. PubMed ID: 11268699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Déjà vu in pap testing: return of the 5% false-negative fraction and the zero-error rate.
    Renshaw AA
    Diagn Cytopathol; 2002 Jun; 26(6):343-4. PubMed ID: 12112821
    [No Abstract]   [Full Text] [Related]  

  • 27. How preventable is invasive cervical cancer? A community study of preventable factors.
    Martin PL
    Am J Obstet Gynecol; 1972 Jun; 113(4):541-8. PubMed ID: 4636632
    [No Abstract]   [Full Text] [Related]  

  • 28. Pitfalls in diagnostic cervicovaginal cytology.
    Sidawy MK; Solomon D
    Monogr Pathol; 1997; (39):1-15. PubMed ID: 9249817
    [No Abstract]   [Full Text] [Related]  

  • 29. Cervical cytology: perspectives from both sides of the Atlantic.
    Bonfiglio TA
    Hum Pathol; 1997 Feb; 28(2):117-9. PubMed ID: 9023389
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of circulation and discussion of cervical smears on agreement between laboratories.
    Ronco G; Montanari G; Confortini M; Parisio F; Berardengo E; Delpiano AM; Arnaud S; Campione D; Baldini D; Poll P; Lynge E; Mancini E; Segnan N
    Cytopathology; 2003 Jun; 14(3):115-20. PubMed ID: 12828719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervix correlated cyto-histological study.
    Gupta S; Rao MC; Gupta IM; Gupta YN; Khanna S; Sanyal SK; Prakash A
    Indian J Pathol Microbiol; 1979 Apr; 22(2):93-6. PubMed ID: 489088
    [No Abstract]   [Full Text] [Related]  

  • 32. [Screening of cervical cancer, false negative smears].
    Vassilakos P; de Marval F; Muñoz M
    Rev Med Suisse Romande; 1998 Jan; 118(1):97. PubMed ID: 9580199
    [No Abstract]   [Full Text] [Related]  

  • 33. Something old and nothing new.
    Somrak TM
    Diagn Cytopathol; 1997 Dec; 17(6):401-2. PubMed ID: 9407195
    [No Abstract]   [Full Text] [Related]  

  • 34. Cervical cancer after negative Papanicolaou smears.
    Hasselbrack R
    Obstet Gynecol; 1985 May; 65(5):771. PubMed ID: 3982757
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality assurance in cervical cytopathology.
    Llewellyn H
    Cytopathology; 1997 Oct; 8(5):349-50; author reply 353-4. PubMed ID: 9313988
    [No Abstract]   [Full Text] [Related]  

  • 36. Challenges in cervical cancer screening: what clinicians, patients and the general public need to know.
    Grohs DH
    Acta Cytol; 1996; 40(1):133-7. PubMed ID: 8604566
    [No Abstract]   [Full Text] [Related]  

  • 37. Automated screening for cervical cancer: diagnostic decision procedures.
    Bartels PH; Wied GL
    Acta Cytol; 1997; 41(1):6-10. PubMed ID: 9022719
    [No Abstract]   [Full Text] [Related]  

  • 38. Pitfalls in the screening and early diagnosis of cervical cancer.
    Wain GV; Hacker NF
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310
    [No Abstract]   [Full Text] [Related]  

  • 39. Anticipating the impact of the new screening guidelines on cytology and molecular laboratories.
    Booth CN
    Cancer Cytopathol; 2013 May; 121(5):225-7. PubMed ID: 23281254
    [No Abstract]   [Full Text] [Related]  

  • 40. Quality assurance in cervical cytopathology.
    Coleman DV; Baker R
    Cytopathology; 1997 Oct; 8(5):350-3; author reply 353-4. PubMed ID: 9313989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.